Skip to main navigation Skip to search Skip to main content

Multi-shelled Dendritic Mesoporous Organosilica Hollow Spheres: Roles of Composition and Architecture in Cancer Immunotherapy

  • Yannan Yang
  • , Yao Lu
  • , Prasanna Lakshmi Abbaraju
  • , Jun Zhang
  • , Min Zhang
  • , Guangya Xiang*
  • , Chengzhong Yu
  • *Corresponding author for this work
  • University of Queensland
  • Huazhong University of Science and Technology

Research output: Contribution to journalArticlepeer-review

Abstract

Developing potent adjuvants for the stimulation of robust immune response is central for effective cancer immunotherapy. Double-shelled dendritic mesoporous organosilica hollow spheres are an excellent adjuvant and provide superior immunity in cancer immunotherapy, and better than their counterparts either with a pure silica composition or a single-walled architecture. This study provides new insights in the rational design of effective nanostructured adjuvants for vaccine developments.

Original languageEnglish
Pages (from-to)8446-8450
Number of pages5
JournalAngewandte Chemie - International Edition
Volume56
Issue number29
DOIs
StatePublished - 10 Jul 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adjuvants
  • antitumor activity
  • immunotherapy
  • multi-shelled materials
  • organosilica

Fingerprint

Dive into the research topics of 'Multi-shelled Dendritic Mesoporous Organosilica Hollow Spheres: Roles of Composition and Architecture in Cancer Immunotherapy'. Together they form a unique fingerprint.

Cite this